The role of monoamine neurotransmitter systems in the nicotine discriminative stimulus

Drug and Alcohol Dependence

Volumn 52, Issue 2, 1998, Pages 125-134

  Mansbach, Robert S ^a   Rovetti, Charles C ^a   Freedland, Cory S ^a  

^a PFIZER INC   (United States)

Author keywords

Dopamine; Drug discrimination; Nicotine; Rat

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; APOMORPHINE; AUTORECEPTOR; BRAIN MONOAMINE; BROMOCRIPTINE; NEUROTRANSMITTER; NICOTINE;

ANIMAL EXPERIMENT; ARTICLE; DISCRIMINATIVE STIMULUS; DOPAMINE RELEASE; DRUG DISCRIMINATION; NEUROTRANSMISSION; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT; REPRODUCIBILITY; SEROTONIN RELEASE; STIMULUS RESPONSE;

ANIMALS; BENZAZEPINES; DISCRIMINATION LEARNING; DOPAMINE AGONISTS; MALE; MOTIVATION; NEUROTRANSMITTER AGENTS; NICOTINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE; RECEPTORS, NICOTINIC;

ANIMALIA;

EID: 0032191925     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(98)00085-4     Document Type: Article

References (48)

1. Andersen P.H., Jansen J.A. Dopamine receptor agonists: selectivity and dopamine D1 receptor efficacy. Eur. J. Pharmacol. Mol. Pharmacol. Sect. 188:1990;335-347.
2. Brazell M.P., Mitchell S.N., Gray J.A. Effect of acute administration of nicotine on in vivo release of noradrenaline in the hippocampus of freely moving rats: a dose-response and antagonist study. Neuropharmacology. 30:1991;823-833.
3. Brioni J.D., Kim D.J.B., O'Neill A.B., Williams J.E.B., Decker M.W. Clozapine attenuates the discriminative stimulus properties of (-)-nicotine. Brain Res. 643:1994;1-9.
4. Chance W.T., Murfin D., Krynock G.M., Rosecrans J.A. A description of the nicotine stimulus and tests of its generalization to amphetamine. Psychopharmacology. 55:1977;19-26.
5. Chumpradit S., Kung M.-P., Vessotskie J., Foulon C., Mu M., Kung H.F. Iodinated 1-aminotetralins and 3-amino-1-benzopyrans: ligands for dopamine D2 and D3 receptors. J. Med. Chem. 37:1994;4245-4250.
6. 3H]dopamine release. Br. J. Pharmacol. 117:1996;595-606.
7. Corrigall W.A., Coen K.M. Nicotine maintains robust self-administration in rats on a limited-access schedule. Psychopharmacology. 99:1989;473-478.
8. Corrigall W.A., Coen K.M. Selective dopamine antagonists reduce nicotine self-administration. Psychopharmacology. 104:1991;171-176.
9. Corrigall W.A., Coen K.M. Dopamine mechanisms play at best a small role in the nicotine discriminative stimulus. Pharmacol. Biochem. Behav. 48:1994;817-820.
10. Corrigall W.A., Coen K.M., Adamson K.L. Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res. 653:1994;278-284.
11. Coward D.M. General pharmacology of clozapine. Br. J. Psychiatr. 160:1992;5-11.
12. De La Garza R., Johanson C.E. The discriminative stimulus properties of cocaine in the rhesus monkey. Pharmacol. Biochem. Behav. 19:1983;145-148.
13. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA. 85:1988;5274-5278.
14. Fici G.J., Wu H., VonVoightlander P.F., Sethy V.H. D1 receptor activity of anti-parkinsonian drugs. Life Sci. 60:1997;1597-1603.
15. Finberg J.P., Youdim M.B. Selective MAO A and B inhibitors: their mechanism of action and pharmacology. Neuropharmacology. 22:1983;441-446.
16. Fowler J.S., Volkow N.D., Wang G.-J., Pappas N., Logan J., MacGregor R., Alexoff D., Shea C., Schlyer D., Wolf A.P., Warner D., Zezulkova I., Cilento R. Inhibition of monoamine oxidase B in the brains of smokers. Nature. 379(6567):1996;733-736.
17. Fowler J.S., Volkow N.D., Wang G.-J., Logan J., Pappas N., Shea C., Zezulkova I. Tobacco smoke reduces human brain MAO: PET studies. Proc. Am. Coll. Neuropsychopharmacol. 1:1996;32.
18. Garattini S., Mennini T., Bendotti C., Invernizzi R., Samanin R. Neurochemical mechanism of action of drugs which modify feeding via the serotoninergic system. Appetite. 7 Suppl:1986;15-38.
19. Graham J.H., Balster R.L. Cocaine-like discriminative stimulus effects of procaine, dimethocaine and lidocaine in rats. Psychopharmacology. 110:1993;287-294.
20. Henningfield J.E., Goldberg S.R. Nicotine as a reinforcer in human subjects and laboratory animals. Pharmacol. Biochem. Behav. 19:1983;989-992.
21. Holtzman S.G. Discriminative stimulus properties of caffeine in the rat: noradrenergic mediation. J. Pharmacol. Exp. Ther. 239:1986;706-714.
22. Iorio L.C., Barnett A., Leitz F.H., Houser V.P., Korduba C.A. SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems. J. Pharmacol. Exp. Ther. 226:1983;462-468.
23. Johanson C.-E., Barrett J.E. The discriminative stimulus effects of cocaine in pigeons. J. Pharmacol. Exp. Ther. 267:1993;1-8.
24. Lee C.M., Javitch J.A., Snyder S.H. Recognition sites for norepinephrine uptake: regulation by neurotransmitter. Science. 220:1983;626-629.
25. Lehmann J., Briley M., Langer S.Z. Characterization of dopamine autoreceptor and [3H]spiperone binding sites in vitro with classical and novel dopamine receptor agonists. Eur. J. Pharmacol. 88:1983;11-26.
26. Mansbach R.S., Brooks E.W., Sanner M.A., Zorn S.H. Selective dopamine D4 receptor antagonists reverse apomorphine-induced blockade of prepulse inhibition. Psychopharmacology. 135:1998;194-200.
27. Matsumoto K., Cai B., Satoh T., Ohta H., Watanabe H. Desipramine enhances isolation-induced aggressive behavior in mice. Pharmacol. Biochem. Behav. 39:1991;167-170.
28. Merchant K.M., Gill G.S., Harris D.W., Huff R.M., Eaton M.J., Lookingland K., Lutzke B.S., McCall R.B., Piercey M.F., Schreur P.J.K.D., Sethy V.H., Smith M.W., Svensson K.A., Tang A.H., Vonvoigtlander P.F., Tenbrink R.E. Pharmacological characterization of U-101387, a dopamine D4 receptor selective antagonist. J. Pharmacol. Exp. Ther. 279:1996;1392-1403.
29. Molinoff P.B. Alpha- and beta-adrenergic receptor subtypes properties, distribution and regulation. Drugs. 28(2 Suppl):1984;1-15.
30. Nader M.A., Mach R.H. Self-administration of the dopamine D3 agonist 7-OH-DPAT in rhesus monkeys is modified by prior cocaine exposure. Psychopharmacology. 125:1996;13-22.
31. Naquira D., Pinardi G., Miranda H.F. Alpha-adrenoceptor and opioid receptor modulation of clonidine-induced antinociception. Br. J. Pharmacol. 119:1996;551-554.
32. Pratt J.A., Stolerman I.P., Garcha H.S., Giardini V., Feyerabend C. Discriminative stimulus properties of nicotine: further evidence for mediation at a cholinergic receptor. Psychopharmacology. 81:1983;54-60.
33. Reavill C., Stolerman I.P. Interaction of nicotine with dopaminergic mechanisms assessed through drug discrimination and rotational behaviour in rats. J. Psychopharmacol. 1:1987;264-273.
34. Ritz M.C., Kuhar M.J. Relationship between self-administration of amphetamine and monoamine receptors in brain: comparison with cocaine. J. Pharmacol. Exp. Ther. 248:1989;1010-1017.
35. Schechter M.D., Cook P.G. Dopaminergic mediation of the interoceptive cue produced by d-amphetamine in rats. Psychopharmacologia. 42:1975;185-193.
36. Schechter M.D., Meehan S.M. Further evidence for the mechanisms that may mediate nicotine discrimination. Pharmacol. Biochem. Behav. 41:1992;807-812.
37. Schechter M.D., Meehan S.M. Dopaminergic mediation of the stimulant generalization of nicotine. Prog. Neuropsychopharmacol. Biol. Psychiatr. 17:1993;835-845.
38. Shoaib M., Schindler C.W., Goldberg S.R. Nicotine self-administration in rats: strain and nicotine pre-exposure effects on acquisition. Psychopharmacology. 129:1997;35-43.
39. Stolerman, I.P., 1987. Psychopharmacology of nicotine: stimulus effects and receptor mechanisms. In: Iversen, L.L., Iversen, S.D. (Eds.), Handbook of Psychopharmacology, vol. 19. Plenum, New York, pp. 421-465.
40. Stolerman I.P. Discriminative stimulus effects of nicotine in rats trained under different schedules of reinforcement. Psychopharmacology. 97:1989;131-138.
41. Stolerman, I.P., Reavill, C., 1989. Primary cholinergic and indirect dopaminergic mediation of behavioral effects of nicotine. In: Nordberg, A., Fuxe, K., Holmstedt B., Sundwall, A. (Eds.) Progress in Brain Research, vol. 79, Nicotinic Receptors in the CNS: Their Role in Synaptic Transmission. Elsevier, Amsterdam, pp. 227-237.
42. Stolerman I.P., Pratt J.A., Garcha H.S., Giardini V., Kumar R. Nicotine cue in rats analyzed with drugs acting on cholinergic and 5-hydroxytryptamine mechanisms. Neuropharmacology. 22:1983;1029-1037.
43. Stolerman I.P., Garcha H.S., Pratt J.A., Kumar R. Role of training dose in discrimination of nicotine and related compounds by rats. Psychopharmacology. 84:1984;413-419.
44. Svensson K., Johansson A.M., Magnusson T., Carlsson A. (+)-AJ76 and (+)-UH232: central stimulants acting as preferential dopamine autoreceptor antagonists. Naunyn-Schmiedeberg's Arch. Pharmacol. 334:1986;234-245.
45. Weed M.R., Vanover K.E., Woolverton W.L. Reinforcing effect of the D1 dopamine agonist SKF 81297 in rhesus monkeys. Psychopharmacology. 113:1993;51-52.
46. Westfall T.C., Grant H., Perry H. Release of dopamine and 5-hydroxytryptamine from rat striatal slices following activation of nicotinic cholinergic receptors. Gen. Pharmacol. 14:1983;321-325.
47. Wise R.A., Murray A., Bozarth M.A. Bromocriptine self-administration and bromocriptine-reinstatement of cocaine-trained and heroin-trained lever pressing in rats. Psychopharmacology. 100:1990;355-360.
48. Yasar S., Schindler C.W., Thorndike E.B., Szelenyi I., Goldberg S.R. Evaluation of the stereoisomers of deprenyl for amphetamine-like discriminative stimulus effects in rats. J. Pharmacol. Exp. Ther. 265:1993;1-6.